We would love to hear your thoughts about our site and services, please take our survey here.
The sticky SP is down to the Bots exercising their control atm, I suspect some clever clogs is accumulating a shed load, and whilst that’s underway, the AT algobots put the brakes on any potential upward movement.
We’ll see how long it lasts , but meanwhile, in the background, rollout continues, sales build, and at some point this will start flying.
Well, over 1M traded ( all buys) so perhaps something is afoot.
I kind of think 5.5p was achieved on licence reinstatement so still sitting at 2.9p (with existing investors investing further considerable amounts at 4p) is bargain territory.
Anyway, let’s see how today pans out.
Morning Paul, yes, I’ve noticed that sudden stock activity has increased prior to news in the past, And I would suggest news is probably due fairly soon, it’s been quiet for several months.
I’m tempted to add but will hold off for now, I’m maintaining a reasonable holding and like all things, patience is required.
However, a few more buys and this will suddenly move, which invariably attracts the attention of those regular names, which were now familiar with.
Strangely enough, this all hinged on whether they got FDA approval, which they now have.
I believe that they are almost there, as identified in todays RNS, the minute any arrangement is made over funding the next 12 months, this will go ballistic.
Over $1.01 now, this will move up in the US when LSE is closed, Gap up tomorrow.
They’ve spent many hundreds of Millions developing this, it’s fallen from $30.00 a share, a buck is extremely cheap, it’s going to get funded.
Yes, they need cash but this is a US driven stock, let’s see what the yanks make of the news.
The SP here will be dictated by them, they’ll raise funds in dollars, Mount Sinai is a big holder, they won’t want massive dilution.
Let’s see how it plays out.
I’ll keep my holding as it is.